# Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

Article · Mikhail Kosiborod, Steen Zabell Abildstrom, Barry A. Borlaug, Javed Butler, Søren Rasmussen, Melanie Jane Davies, G. Kees Hovingh, Dalane W. Kitzman, Marie L.S. Lindegaard, Daniél V. Møller, Sanjiv Jayendra Shah, Marianne Bach Treppendahl, Subodh Verma, Walter P. Abhayaratna, Fozia Zahir Ahmed, Vijay Chopra, Justin Adrian Ezekowitz, Michael L.X. Fu, Hiroshi Ito, Małgorzata Lelonek, Vojtěch Melenovský, Béla Péter Merkely, Julio E. Núñez, Eduardo Roque Perna, Morten Schou and 6 more

- Archive id: doi:10.1056/nejmoa2306963
- Published: 2023-08-25
- Venue: New England Journal of Medicine
- DOI: https://doi.org/10.1056/nejmoa2306963
- PMID: 37622681
- Citations: 1,661
- Source URL: https://doi.org/10.1056/nejmoa2306963
- PDF: https://www.nejm.org/doi/pdf/10.1056/NEJMoa2306963
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

Cited in dossiers:
- [GLP-1 & Incretin Therapies: State of the Field (October 2026)](https://space-kitty.com/dossiers/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.